Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea.
Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.
Korean J Intern Med. 2022 Sep;37(5):885-894. doi: 10.3904/kjim.2022.138. Epub 2022 Jul 29.
Inflammatory bowel disease (IBD) refers to a group of disorders, including Crohn's disease and ulcerative colitis, that exhibit similar but distinct manifestations. These diseases are characterized by refractory and chronic inflammation of the bowel. IBD is usually accompanied by severe symptoms. When a patient presents with suspected IBD, physicians encounter various challenges in terms of diagnosis and treatment. In addition, given such characteristics, the associated medical expenses gradually increase. Although IBD was formerly known as a disease of Western countries, the incidence and prevalence are increasing in Korea. Korean investigators have accumulated a great deal of knowledge about the regional characteristics and epidemiology of the disease, especially via well-organized, joint cohort studies. Against this background, this article describes the epidemiology of IBD in Korea compared to that in the West. In addition, an overview of the pathophysiology of the disease is provided, focusing on the latest results.
炎症性肠病(IBD)是一组疾病,包括克罗恩病和溃疡性结肠炎,它们具有相似但不同的表现。这些疾病的特点是肠道难治性和慢性炎症。IBD 通常伴有严重的症状。当患者出现疑似 IBD 时,医生在诊断和治疗方面会遇到各种挑战。此外,由于这些特点,相关医疗费用逐渐增加。虽然 IBD 以前被称为西方国家的疾病,但在韩国,其发病率和患病率正在上升。韩国研究人员通过精心组织的联合队列研究,积累了大量关于该疾病区域特征和流行病学的知识。在此背景下,本文描述了韩国与西方的 IBD 流行病学情况。此外,还概述了疾病的病理生理学,重点介绍了最新的研究结果。